Stealth startup R3 Bio raises funds for clones

The stealth startup R3 Bio, based in California, has recently announced it has raised capital to develop nonsentient monkey "organ sacks." Operating in secrecy for several years, the company's specific goals and the implications of its research remain largely undisclosed. This development is part of a broader trend in biotechnology and AI research exploring novel applications and ethical considerations. Further details regarding the funding amount and the specific scientific objectives are expected to emerge as the company progresses.